Skip to main content
. 2020 Jul 1;10:10740. doi: 10.1038/s41598-020-67563-9

Figure 7.

Figure 7

The effect of CIMVs-MSCs on viability of spleen, thymus and bone marrow leukocytes in vitro. Negative control—leukocytes incubated 24 h before the analysis; CIMVs-MSCs—leukocytes incubated with CIMVs-MSCs (15 µg) for 24 h before the analysis. Leukocytes were washed, stained with Annexin V-PI kit and analyzed by flow cytometer FACS Aria III.